Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438

Conditions
B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Uniklinik RWTH Aachen Aachen, Germany
  • Charité - Campus Benjamin Franklin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
View all 21 locations
View Trial Details
Completed

A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04773522

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Shonan Kamakura General Hospital Kamakura-shi, Japan
  • National Cancer Center Hospital East Kashiwa, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • National Hospital Organization Okayama Medical Center Okayama, Japan
View Trial Details
Completed

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

NCT04984356

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik Munich, Bavaria, Germany
  • phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg Aschaffenburg, Germany
  • Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie Bamberg, Germany
  • Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main Frankfurt am Main, Germany
View Trial Details

Related conditions